Insights from molecular network analysis to docking of sterubin with potential targets.

Sittarthan Viswanathan, Kavimani Subramanian, Vimalavathini Ramesh, A Hannah Rachel Vasanthi

Abstract read

In one paragraph

Article in Bioinformation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Discovery of Anoikis-correlated Biomarkers for Ovarian Cancer Through Integrated Transcriptome and Single-cell RNA Sequencing Analyses.Current topics in medicinal chemistry · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sittarthan ViswanathanDepartment of Pharmacology, Mother Theresa Post Graduate & Research Institute of Health Sciences (Government of Puducherry Institution), Puducherry - 605006, India.

Kavimani SubramanianDepartment of Pharmacology, Mother Theresa Post Graduate & Research Institute of Health Sciences (Government of Puducherry Institution), Puducherry - 605006, India.

Vimalavathini RameshDepartment of Pharmacology, Mother Theresa Post Graduate & Research Institute of Health Sciences (Government of Puducherry Institution), Puducherry - 605006, India.

A Hannah Rachel VasanthiDepartment of Biotechnology, Pondicherry University - 605014.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of a flavonoid compound sterubin in drug discovery is gaining momentum. Hence, it is of interest to document the molecular network analysis to docking of sterubin with potential targets to glean insights. We identified 32 target genes and (or) gene products for sterubin using DAVID tools for GO, KEGG pathway enrichment analyses and the STRING database. Further, molecular docking analysis data of sterubin with these targets is documented for further consideration in broad-spectrum drug discovery.

Indexed as

Alzheimer's diseaseEriodicyton californicummolecular dockingnetwork analysisSterubin

Identifiers

PMID38250532

DOI10.6026/973206300191184

PMCPMC10794762

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.